Sinco Pharmaceuticals Holdings Limited, is the third largest provider of marketing, promotion and channel management, or MPCM services in China’s pharmaceutical market with a share of 6.4% based on revenue in 2014. Sincopharm’s product portfolio comprises imported pharmaceutical products in the plasma-based pharmaceuticals segment as well as other fast-growing or sizeable segments in China. The company provides integrated MPCM services to small and medium-sized overseas pharmaceutical manufacturers that do not have on-the-ground marketing and promotion capabilities in China, enters into long-term agreements with suppliers, generates profits by selling the imported pharmaceutical products to the distributors across China. For expanding Sincopharm's business needs and developments, Sinco (Shanghai) Trading Co., Ltd was founded in Shanghai, September 2016. With the core values of Sincopharm. (Simplicity, Innovation, National, Collaboration, Openness) Fellows, you’d be extremely welcome to join us for exploring all the diversity opportunities with us!
Looking for a particular Sincopharm employee's phone or email?
Sincopharm Questions
The Sincopharm annual revenue was $302.5 million in 2026.
Yang Yukai is the COO of Sincopharm.
1 people are employed at Sincopharm.
The NAICS codes for Sincopharm are [551, 55].
The SIC codes for Sincopharm are [67, 671].
Top Sincopharm Employees
-
Yang Yukai
Chief Operating Officer at Sincopharm
Shanghai, China2
Related Companies
